Catheter Securement & Stabilization
Device That Works.

Coast Med Ventures brings CathAttach — a patented catheter securement & stabilization device — to hospitals and clinics throughout North America. Clinically evaluated at the University of Florida with a 97% success rate across 120 placements.

Request a Quote View Clinical Data

Patented · FDA Registered

CathAttach

Catheter Securement & Stabilization Device · 6F–12F

  • Innovative Patented Securement & Stabilization MechanismPhysically prevents accidental dislodgement and retraction — where sutures and available fixation devices cannot.
  • Safety Slack Before LockNatural catheter motion allowed prior to engagement — prevents kinking and twisting.
  • Soft Material · Under 10mm ProfileHydrocolloid patch base — secure placement, easy removal, superior patient comfort.

Status: Available Now

Product Code: CA0612 · QTY/BOX: 10

IP Status
Patented Device
Validated
University of Florida IR
Study Outcome
97% Success Rate
Coverage
USA & Canada
Product Code
CA0612
Qty / Box
10 units
Catheter Size Range
6F – 12F
Profile Height
< 10mm
Replacement Interval
Every 7 days

CathAttach — A Secured Locking Mechanism, Not Just a Hold

Existing securement options — sutures and available fixation devices — hold the catheter in place but cannot prevent patients from accidentally retracting or deliberately pulling them out. CathAttach’s patented securement & stabilization mechanism changes the equation entirely.

  • Patented Securement & Stabilization Mechanism

    A true secured locking design that physically prevents retraction and accidental dislodgement — superior to suture-only and conventional securement across nephrostomy, biliary, cholecystostomy, suprapubic, nephroureteral, and ascites catheter types.

  • Safety Slack Before Lock Engages

    Engineered safety slack allows natural catheter motion prior to locking — preventing kinking and twisting while securing catheter integrity throughout the dwell period.

  • Hydrocolloid Base — Easy On, Easy Off

    The hydrocolloid patch provides secure skin adhesion and atraumatic removal. The low-profile design (under 10mm) with soft body construction optimizes patient comfort and allows access to the wound site for cleaning and disinfecting.

  • Patient-Managed Replacement

    Designed for routine replacement every 7 days by the patient at home — reducing return visits, lowering cost of care, and extending catheter dwell time without clinical intervention.

Request Pricing & Samples

Validated at the University of Florida

CathAttach was formally evaluated in a 6-month clinical study conducted by the Interventional Radiology department at the University of Florida. The study assessed 120 CathAttach placements across 63 patients with drainage catheters including nephrostomy, biliary, cholecystostomy, suprapubic, nephroureteral, and ascites catheters.

“Our evaluation of the CathAttach catheter securement & stabilization device demonstrated better outcome when compared to current securement options, and it provided a more effective way to secure drainage catheters sizes 6 French through 12 French.”

— Sean Wiley, RRA/RPA & Benjamin Berwick, MD · Interventional Radiology, University of Florida

Of 61 patients who followed the replacement protocol, zero experienced early returns for misposition or dislodgement. Five patients reported that CathAttach also reduced catheter leaking previously experienced with suture-only securement. All 61 adherent patients rated the device as comfortable, easy to replace, and effective.

Download Full Clinical Study (PDF)

University of Florida · IR Department · 6-Month Study

Evaluation of CathAttach for Dislodgement & Malposition in Drainage Catheters 6F–12F

Sean Wiley, RRA/RPA & Benjamin Berwick, MD

Patients Evaluated
63
Total Placements
120
Early Returns for Dislodgement (compliant patients)
0
Patient Satisfaction Rate
97%
Published Dislodgement Rate — Standard Devices
5–25%
Catheter Types Studied
6
Download Study PDF

Built for Every Setting Where Drainage Catheters Are Placed

CathAttach is available directly to hospitals, IR departments, clinics, and healthcare networks throughout the United States and Canada.

Hospital IR Departments

The primary setting for CathAttach. IR departments placing nephrostomy, biliary, cholecystostomy, suprapubic, and ascites catheters benefit directly from eliminated dislodgement returns and reduced unplanned ER visits.

Outpatient & OBL Settings

Office-based labs and ambulatory surgery centers need reliable securement with simple procurement. CathAttach delivers hospital-grade performance — and patients manage routine replacement themselves at home.

Home Health & Long-Term Care

CathAttach’s 7-day replacement cycle and patient-friendly design make it ideal for home management. Patients in the UF study rated it comfortable and easy to replace independently — reducing clinical follow-up frequency and cost.

See CathAttach In Action

Watch the product demonstration, then download the clinical study and product brochure below.

Product Demonstration

CathAttach — Catheter Securement & Stabilization Device

Watch on YouTube

Product Brochure · PDF

CathAttach Product Overview & Specifications

Full product features, sizing guide (6F–12F), product code CA0612, and ordering information.

Download Brochure

Clinical Study · PDF

University of Florida IR — Peer-Reviewed Evaluation

6-month, 63-patient study evaluating dislodgement, comfort, and outcomes vs. standard devices.

Download Study

Ordering Document

Pricing & Purchase Information

Contact our team for current pricing, GPO contract options, and volume purchasing details.

Request Pricing

See Your Hospital’s Potential Savings

Enter your facility’s catheter volume and device cost to instantly see how much CathAttach could save your hospital each year in avoided dislodgement costs.

CathAttach™ VAC — Cost Benefit Calculator Interactive Estimate

Your facility’s average monthly drainage catheter placements.

Per-device cost. Contact us for volume pricing.

Model Assumptions (click to view)

Avg Dislodgement Rate

5 per 100 placed

Avg Cost per Dislodgement

$1,500

Dislodgements Prevented

1 per month

Monthly Dislodgements

3.0 /mo

Monthly Dislodgement Cost

$4,500

Monthly CathAttach Cost

$1,200

Estimated Savings Over Current Practices

Your Hospital’s Projected Annual Benefit

2.75x benefit–cost ratio — every $1 spent returns this in avoided costs

Per Month

$3,300

Per Year

$39,600

Request Pricing & Samples

Estimates based on published national dislodgement rates and average dislodgement costs. Actual results vary by facility.

Ready to Get Started?

Complete the form to request pricing, samples, the product brochure, or a purchasing conversation. We serve hospitals, IR departments, clinics, and networks throughout the United States and Canada.

Headquarters

Ponte Vedra, Florida

Orders & Inquiries

orders@coastmedventures.com

Distribution Partners

partners@coastmedventures.com

Product Code

CA0612 · 10 units/box

Request Pricing, Sample or Brochure

We respond within 1 business day.

Fields marked * are required.

We will only use this to respond to your inquiry.

Specialists in Medical Device Importation

Coast Med Ventures, LLC is a medical device importation company based in Ponte Vedra, Florida, focused on bringing clinically validated, high-quality devices to healthcare providers throughout North America. We manage the full importation, regulatory, and distribution process — giving clinical and procurement teams access to better solutions without complexity.

Our leadership team brings decades of combined experience in medical device sales, global distribution, and market development — with a proven track record of growing product lines from launch to national scale across more than 46 countries.

CathAttach is our flagship North American offering — a patented, peer-reviewed device that addresses one of the most persistent and costly challenges in interventional medicine. We welcome conversations with healthcare facilities and distribution partners.

Countries — Leadership Experience
46+
North America Coverage
US & CA
Patient Satisfaction — UF Clinical Study
97%
Early Dislodgement Returns — Compliant Patients
0